ANXA2 and breast cancer: Our previous analysis of the Cancer Genome Atlas (TCGA) cohort of 113 TNBC patients showed a poor survival rate due to high AnxA2 tissue mRNA expression compared to ER-positive, PR- positive, and HER2-positive breast cancer patients [55].